Skip to main content
OpenTrials
Completed

NCT Number: NCT01131650

Prevalence of Diabetic Retinopathy in São José do Rio Preto-SP-Brazil

Prevalence of Diabetic Retinopathy in São José do Rio Preto-SP-Brazil

Abstract

Objective: To determine the prevalence and characteristics of diabetic retinopathy (DR) among patients from São José do Rio Preto-SP-Brazil .

Local: Departamento de Retina e Vítreo do Hospital do Olho de Rio Preto (HORP)

Methods: Design: population-based cross-sectional study. The study sample, of 710 patients was derived from the HIPERDIA (Diabetes and High-blood pressure social health care program) of São José do Rio Preto . All patients , known to have diabetes , underwent an eye examination by biomicroscope and indirect ophthalmoscope to check for any signs of DR through dilated pupils. Participants were also interviewed and examined to determine their demographic characteristics, medical conditions and the realization of previous fundoscopic eye examination. Statistical studies were done with t -Student test , Fisher test or chi-square test.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Carlos Eduardo Cury Junior

São José do Rio Preto, São Paulo, 15090500, Brazil

About this study

Prevalence of Diabetic Retinopathy in São José do Rio Preto-SP-Brazil

Abstract

Objective: To determine the prevalence and characteristics of diabetic retinopathy (DR) among patients from São José do Rio Preto-SP-Brazil .

Local: Departamento de Retina e Vítreo do Hospital do Olho de Rio Preto (HORP)

Methods: Design: population-based cross-sectional study. The study sample, of 710 patients was derived from the HIPERDIA (Diabetes and High-blood pressure social health care program) of São José do Rio Preto . All patients , known to have diabetes , underwent an eye examination by biomicroscope and indirect ophthalmoscope to check for any signs of DR through dilated pupils. Participants were also interviewed and examined to determine their demographic characteristics, medical conditions and the realization of previous fundoscopic eye examination. Statistical studies were done with t -Student test , Fisher test or chi-square test.

Results: Among 710 screened patients 112 had some degree of diabetic retinopathy and the overall standardized prevalence of any retinopathy was 16,3%., including 90 (80,4%) with non-proliferative and (22) 19,6 % with proliferative diabetic retinopathy. Only 143 patients (68,7%) had a history of previous fundoscopic eye examination.

Conclusion: This study demonstrated that DM and their complications are a important public health problem. The duration of DM and glicemic control is strongly associated with DR . Prevention programs with periodic fundoscopic exams shows to diminished the prevalence of this ocular disease.

Keywords: Diabetes, Retinopathy, Prevalence, Population.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with Diabetes Melittus

Exclusion criteria

  • Patients without Diabetes Melittus

Treatment and study plan

Primary outcomes

  1. Prevalence of diabetic retinopathy

Secondary outcomes

  1. associated risk factors of diabetic retinopathy

Sponsors and collaborators

Lead sponsor

Hospital do Olho Rio Preto

Other

Collaborators

  • Faculty of Medicine of Ribeirão Preto (FMRP-USP)

Registry information

Important dates

Study start
2009
Primary completion
2009
Study completion
2010
First posted
May 27, 2010
Registry last updated
May 27, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.